Investigation into Fractyl Health, Inc. on Behalf of Investors

Fractyl Health, Inc. is being investigated by the DJS Law Group on behalf of investors for potential securities law violations. The investigation focuses on whether the company issued misleading statements or failed to disclose information pertinent to investors. The company's stock fell 67.48% after Benzinga reported that Fractyl Health requested FDA feedback on potentially reclassifying Revita under the De Novo pathway. If you are a shareholder who suffered a loss, contact the DJS Law Group to participate in the investigation.